Study to Assess SLN124 in Patients With Polycythemia Vera
Clinical trial NCT05499013 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05499013
- Sponsor
- Silence Therapeutics plc
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-01-26
- Primary completion
- 2026-09-01
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.